Investegate |Sanofi - Aventis Groupe Announcements | Sanofi - Aventis Groupe: Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease

Investegate announcements from Sanofi - Aventis Groupe, Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease

Related Keywords

Japan ,Germany ,Facit ,Lancashire ,United Kingdom ,Paris ,France General ,France ,Japanese ,Eva Schaefer Jansen ,Corentine Driancourt ,Felix Lauscher ,Kate Conway ,Nathalie Pham ,Sandrine Guendoul ,Dietmar Berger ,Sally Bain ,Priya Nanduri ,European Commission ,Drug Administration ,Nasdaq ,University Hospital ,University Of Duisburg ,Global Head Of Development At Sanofi ,Japanese Ministry Of Health ,European Medicines Agency ,Department Of Hematology ,Euronext ,Press Release ,Medical Officer ,Global Head ,Stem Cell Transplantation ,Functional Assessment ,Chronic Illness Therapy ,Japanese Ministry ,Private Securities Litigation Reform Act ,Statement Regarding Forward Looking ,Investegate Announcements ,Investegate Company Announcements ,Sanofi Aventis Groupe ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,